Overall rank by patents
#32,215
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 3 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).
The verdict
According to USPTO PatentsView, Kairish ranks #32,215 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 3 technology areas.
USPTO PatentsView assignee plate
Corpus R32215 · Foreign Corporation #32,215 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Kabushiki Kaisha Dnaform (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Kairish Innotech… · this assignee
40 score
3D Lighting… · lowest
7 score
What this shows Kairish's Innovation Score is 39.8/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Kairish Innotech Private Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 37.5% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2024 (4 grants) versus a trough of 2 in 2023. By volume, Kairish sits between Kabushiki Kaisha Dnaform and Kardex Produktion Deutschland GMBH.
Kairish Innotech Private Ltd. shows 6 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Kabushiki Kaisha Dnaform
8 patents
Kabushiki Kaisya Leben Hanbai
8 patents
Kaia Health Software GMBH
8 patents
Kaijet Technology International Corporation
8 patents
Kanazawa Medical University
8 patents
Kansai Coke AND Chemicals Co., Ltd.
8 patents
Kapro Industries Ltd.
8 patents
Kardex Produktion Deutschland GMBH
8 patents
Kairish Innotech Private Ltd.
8 patents
What this shows Kairish holds 8 patents at rank #32,201, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,201 in granted patent volume.
Other assignees with the most granted patents in Kairish's primary technology class.
Kairish's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 2 | 25.0% |
| 2024 | 4 | 50.0% |
| 2025partial year | 2 | 25.0% |
Top 3 of 3 technology areas
Overall rank by patents
#32,215
of 49,997 tracked assignees
39.8 out of 100
What to do with this data
Kairish Innotech Private Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.